Learn About Usher Syndrome

What is the definition of Usher Syndrome?

Usher syndrome is a condition characterized by partial or total hearing loss and vision loss that worsens over time. The hearing loss is classified as sensorineural, which means that it is caused by abnormalities of the inner ear. The loss of vision is caused by an eye disease called retinitis pigmentosa (RP), which affects the layer of light-sensitive tissue at the back of the eye (the retina). Vision loss occurs as the light-sensing cells of the retina gradually break down. Loss of night vision begins first, followed by blind spots that develop in the side (peripheral) vision. Over time, these blind spots enlarge and merge to produce tunnel vision. In some cases, vision is further impaired by clouding of the lens of the eye (cataracts). However, many people with retinitis pigmentosa retain some central vision throughout their lives.

What are the causes of Usher Syndrome?

Usher syndrome can be caused by mutations in several different genes. Mutations in at least six genes can cause Usher syndrome type I. The most common of these are MYO7A gene mutations, followed by mutations in the CDH23 gene. Usher syndrome type II can result from mutations in three genes; USH2A gene mutations account for most cases of type II. Usher syndrome type III is most often caused by mutations in the CLRN1 gene.

How prevalent is Usher Syndrome?

Usher syndrome affects around 4 to 17 in 100,000 people. Types I and II are the most common forms of Usher syndrome in most countries. Certain genetic mutations resulting in type 1 Usher syndrome are more common among people of Ashkenazi (eastern and central European) Jewish or French Acadian heritage than in the general population.

Is Usher Syndrome an inherited disorder?

All of the types of Usher syndrome are inherited in an autosomal recessive pattern, which means both copies of a gene in each cell have a mutation. The parents of an individual with Usher syndrome each carry one copy of the mutated gene, but they do not have any signs and symptoms of the condition.

Who are the top Usher Syndrome Local Doctors?
Ophthalmology
Ophthalmology

Community Health Programs Inc

Great Barrington, MA 
 (1.9 mi)
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Diane Singer is an Ophthalmologist in Great Barrington, Massachusetts. Dr. Singer and is rated as an Experienced provider by MediFind in the treatment of Usher Syndrome. Her top areas of expertise are Meibomianitis, Ocular Hypertension (OHT), Chalazion, and Eyelid Bump. Dr. Singer is currently accepting new patients.

Ophthalmology | General Surgery
Ophthalmology | General Surgery

Associated Retinal Consultants LLC

628 Cedar Ln, 
Teaneck, NJ 
 (96.5 mi)
Languages Spoken:
English, Spanish
Accepting New Patients

Paul Hahn is an Ophthalmologist and a General Surgeon in Teaneck, New Jersey. Dr. Hahn and is rated as an Advanced provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Endophthalmitis, Vitrectomy, and Cataract Removal. Dr. Hahn is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Ophthalmology
Ophthalmology

Albany Troy Cataract And Laser Associates

2222 6th Ave, 
Troy, NY 
 (40.7 mi)
Languages Spoken:
English, Spanish
Accepting New Patients

David Rabady is an Ophthalmologist in Troy, New York. Dr. Rabady and is rated as a Distinguished provider by MediFind in the treatment of Usher Syndrome. His top areas of expertise are Adult-Onset Vitelliform Macular Dystrophy (AVMD), Usher Syndrome Type 2A, Cone-Rod Dystrophy, and Cone Dystrophy. Dr. Rabady is currently accepting new patients.

What are the latest Usher Syndrome Clinical Trials?
A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

Summary: The purpose of this Phase 2b study is to evaluate the safety and tolerability of Ultevursen administered via intravitreal injection (IVT) in subjects with Retinitis Pigmentosa (RP) due to mutations in exon 13 of the USH2A gene. This is a multicenter Double-masked, Randomized, Sham-controlled study which will enroll 81 subjects.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1/2 Multicenter, Open-label, Dose Escalation, Safety and Efficacy Study of Subretinal Administration of Dual AAV8.MYO7A, AAVB-081 in Subjects With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa

Summary: The purpose of the 081-101 study is to evaluate the safety and tolerability of a single subretinal injection of AAVB-081 in USH1B patients with retinitis pigmentosa due to a mutation in the MYO7A gene. The study will also assess the initial efficacy following AAVB-081 administration.

Who are the sources who wrote this article ?

Published Date: May 17, 2021
Published By: National Institutes of Health